YDES
YD Bio Ltd
NASDAQ: YDES · HEALTHCARE · BIOTECHNOLOGY
$5.11
-1.53% today
Updated 2026-04-30
Market cap
$385.05M
P/E ratio
—
P/S ratio
754.46x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$5 – $25
Volume
0.0M
YD Bio Ltd (YDES) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-276.60%
Operating margin
-444.60%
ROE
-42.70%
ROA
-25.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-2.54M | — | — | — |
| 2021 | — | $8.70M | — | — | — |
| 2022 | — | $3.79M | — | — | — |
| 2023 | $350131.00 | $13560.00 | 43.83% | -2.81% | 3.87% |
| 2024 | $510360.00 | $-1.41M | 30.44% | -286.45% | -276.58% |